Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
74
days
Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States
Authors
Aaron Nagiel; Stephen R. Russell; Byron L. Lam; Jason I. Comander; Tomas S. Aleman; Cagri G. Besirli; Robert A. Sisk; Paul Yang; Christina Y. Weng; Daniel C. Chung; Aishwarya Thakre; Juha-Matti Savola; David L. RoussoShow moreShow less
Affiliations
Department of Surgery, Vision Center – Ophthalmology, Children’s Hospital Los Angeles, Los Angeles, California; Department of Ophthalmology, Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; Inherited Retinal Disorders Service, Massachusetts Eye and Ear, Boston, Massachusetts; Department of Ophthalmology, Scheie Eye Institute and The Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Michigan Health System, Ann Arbor, Michigan; Cincinnati Eye Institute, Blue Ash, Ohio; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon; Baylor College of Medicine, Ophthalmology-Cullen Eye Institute, Houston, Texas; Beacon Therapeutics, Cambridge, Massachusetts; Spark Therapeutics, Inc, Philadelphia, PennsylvaniaShow moreShow less
208
days
Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes with Geographic Atrophy
Authors
Justis P. Ehlers; Hasan Cetin; Reem Amine; Karen Matar; Asmita Indurkar; John Mamone; Lyndsey Della Vecchia; Amy Tang; Jamie Reese; Don Luo; Dina Joy K. Abulon; Katherine E. TalcottShow moreShow less
Affiliations
The Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Astellas Pharma Inc, Northbrook, IllinoisShow moreShow less
258
days
Glaucoma in the UK Biobank
Authors
William Schierding; Aldric Khoo; Emma Akeroyd; Adam S. Butterworth; John Danesh; Helen V. Danesh-MeyerShow moreShow less
Affiliations
Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand; Vision Research Foundation, Auckland, New Zealand; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, United Kingdom; British Heart Foundation Centre of Research Excellence, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom; Health Data Research UK, Wellcome Genome Campus and University of Cambridge, Hinxton, United Kingdom; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, United Kingdom; Department of Human Genetics, Wellcome Sanger Institute, Hinxton, United KingdomShow moreShow less
76
days
The Effects of a Digital Mindfulness Intervention on Mental Health and Vision-Related Quality of Life in Noninfectious Uveitis
Authors
Jessica G. Shantha; Isabel Ray; Anika Kumar; Daisy Yan; Kirsten Da Silva; Charlene Choo; Alison B. Coyne; Emily Tang; John A. Gonzales; Thuy Doan; Benjamin F. Arnold; Thomas Lietman; Nisha R. AcharyaShow moreShow less
Affiliations
Emory University, Department of Ophthalmology, Atlanta, Georgia; F.I. Proctor Foundation, University of California San Francisco, San Francisco, California; Department of Ophthalmology, University of California San Francisco, San Francisco, California; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CaliforniaShow moreShow less
138
days
Polygenic Risk Impacts Lifetime Risk and Prognosis of Glaucoma
Authors
Eemeli S. Tusa; Max Tamlander; Samuli Ripatti; Mika Harju; Karita Salo; Joni A. Turunen; Nina MarsShow moreShow less
Affiliations
Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland; Massachusetts General Hospital, Boston, Massachusetts; Department of Public Health, University of Helsinki, Helsinki, Finland; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Eye Genetics Group, Folkhälsan Research Center, Helsinki, FinlandShow moreShow less
120
days
Large Language Model Authorship in Ophthalmic Publications
Authors
Christopher R. Fortenbach; Yue S. Wu; Parth M. Mungra; Russell N. Van GelderShow moreShow less
Affiliations
Department of Ophthalmology, University of Washington School of Medicine, Seattle, Washington; Karalis-Johnson Retina Center, Department of Ophthalmology, University of Washington School of Medicine, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; Department of Neurobiology & Biophysics, University of Washington, Seattle, WashingtonShow moreShow less
FAQ
How long does OPHTHALMOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for OPHTHALMOLOGY. The fastest paper went from submission to acceptance in 74 days (Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States, received 2026-04-27, accepted 2026-07-10); the slowest took 258 days. The average is 128.6 days and the median is 123.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
